HRT Financial’s Bionano Genomics BNGO Stock Holding History

HRT Financial’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13K	Buy	+11,740	New	+$14.1K	﹤0.01%	3963
2025 Q4	–	Sell	-20,330	Closed	-$34K	–	3213
2025 Q3	$34K	Buy	+20,330	New	+$64.6K	﹤0.01%	2639
2024 Q2	–	Sell	-350	Closed	-$23K	–	2257
2024 Q1	$23K	Buy	+350	New	+$26.1K	﹤0.01%	1997
2023 Q3	–	Sell	-81	Closed	-$29K	–	2425
2023 Q2	$29K	Buy	81 +63	+350%	+$28.4K	﹤0.01%	2067
2023 Q1	$12K	Buy	+18	New	+$16K	﹤0.01%	2234
2022 Q2	–	Sell	-46	Closed	-$70K	–	2963
2022 Q1	$70K	Buy	46 +29	+171%	+$39.1K	﹤0.01%	2713
2021 Q4	$31K	Buy	+17	New	+$45.5K	﹤0.01%	2901
2021 Q2	–	Sell	-1,552	Closed	-$7.52M	–	2866
2021 Q1	$7.52M	Buy	+1,552	New	+$8.75M	0.08%	187

Other funds holding BNGO

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

CAM

Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

HRT Financial's BNGO Position: Q2 2026 in Review

HRT Financial opened a new position in Bionano Genomics (BNGO) in Q2 2026: 11,740 shares worth $13K. The stake represents ﹤0.01% of the portfolio and ranks #3963 among its holdings. This is a return to the name: HRT Financial previously reported a position in BNGO as recently as Q3 2025.

HRT Financial first reported a position in BNGO in Q1 2021 and has held it in 8 quarters since. The position peaked at $7.52M in Q1 2021. 34 funds tracked by Wall St. Rank hold BNGO as of Q2 2026.

HRT Financial held 11,740 shares of Bionano Genomics worth $13K as of Q2 2026.
Bionano Genomics was a new HRT Financial position in Q2 2026.
Bionano Genomics made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3963 holding.
HRT Financial first reported a position in Bionano Genomics in Q1 2021 and has held it in 8 quarters since.
HRT Financial's Bionano Genomics position peaked at $7.52M in Q1 2021.
34 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.